[First results by means of non-ionic contrast medium (Iopamidol) in urography and angiography (author's transl)]. 1980

M Corsi, and C Moretti, and P Biasizzo

The non-ionic water-soluble contrast medium Iopamidol was used for urography in 10 patients and for angiography in 20 patients. In every investigation excellent visualization was obtained and non adverse reaction occurred. Good tolerability to Iopamidol permitted to carry out painless peripheral angiography and translumbar angiography without general anaesthesia.

UI MeSH Term Description Entries
D007479 Iopamidol A non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiological procedures. B-15,000,B-15000,Gastromiro,Iopamidol, (+-)-Isomer,Iopamidol, (R)-Isomer,Iopamidol, Sodium Salt, (S)-Isomer,Iopamiro,Isovue,Isovue 370,Jopamidol,Niopam,SQ 13,396,Solutrast,Solutrast 370,Solutrast Gastro,B 15,000,B 15000,B15,000,B15000
D007483 Iothalamic Acid A contrast medium in diagnostic radiology with properties similar to those of diatrizoic acid. It is used primarily as its sodium and meglumine (IOTHALAMATE MEGLUMINE) salts. Iotalamic Acid,Methalamic Acid,Angio-Conray,Conray 420,Iodothalamate,Iothalamate,Iothalamic Acid, Calcium (2:1) Salt,Iothalamic Acid, Monosilver (1+) Salt,Iothalamic Acid, Monosodium Salt,Iothalamic Acid, Monosodium Salt, Dimer,Lopamidol,Sodium Iothalamate,Acid, Iotalamic,Acid, Iothalamic,Acid, Methalamic,Angio Conray,AngioConray,Iothalamate, Sodium
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000792 Angiography Radiography of blood vessels after injection of a contrast medium. Arteriography,Angiogram,Angiograms,Angiographies,Arteriographies
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D014567 Urography Radiography of any part of the URINARY TRACT. Pyelography,Pyelogram,Urogram,Pyelograms,Pyelographies,Urograms,Urographies

Related Publications

M Corsi, and C Moretti, and P Biasizzo
January 1984, Nihon geka hokan. Archiv fur japanische Chirurgie,
M Corsi, and C Moretti, and P Biasizzo
July 1977, Ceskoslovenska radiologie,
M Corsi, and C Moretti, and P Biasizzo
March 1982, Clinical radiology,
M Corsi, and C Moretti, and P Biasizzo
January 1981, La Radiologia medica,
M Corsi, and C Moretti, and P Biasizzo
November 1987, Rontgenpraxis; Zeitschrift fur radiologische Technik,
M Corsi, and C Moretti, and P Biasizzo
March 1986, La Radiologia medica,
M Corsi, and C Moretti, and P Biasizzo
April 1980, Neuroradiology,
M Corsi, and C Moretti, and P Biasizzo
February 1989, Wiener medizinische Wochenschrift (1946),
M Corsi, and C Moretti, and P Biasizzo
November 1983, Nihon geka hokan. Archiv fur japanische Chirurgie,
M Corsi, and C Moretti, and P Biasizzo
July 1981, Clinical radiology,
Copied contents to your clipboard!